- Home
- CISS vs SXTC Comparison
CISS vs SXTC Comparison
Compare CISS & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | SXTC |
|---|---|---|
| Founded | 2022 | 2005 |
| Country | Greece | China |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 2.0M |
| IPO Year | 2022 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CISS | SXTC |
|---|---|---|
| Price | $1.76 | $2.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.0M | ★ 23.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.03 |
| 52 Week High | $5.93 | $6.98 |
Technical Indicators
Market Signals| Indicator | CISS | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 54.88 |
| Support Level | $1.44 | $1.21 |
| Resistance Level | $2.09 | $2.37 |
| Average True Range (ATR) | 0.27 | 0.39 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 26.32 | 16.82 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.